Clinical Trials Related to Squamous Cell Carcinoma

Related studies linked through entity extraction aliases.

A Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) (Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180)) in Japanese Participants With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC) or Locally Advanced (LA) Unresectable cSCC (MK-3475A-E39)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Surgical Treatment of Stage T3 Squamous Cell Carcinomas of the Scalp

Status: ACTIVE_NOT_RECRUITING
Phase: N/A

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

Status: AVAILABLE
Phase: N/A

Prognostic Immune Biomarkers in HNSCC

Status: COMPLETED
Phase: N/A

Topical Ascorbic Acid for Treatment of Squamous Cell Skin Cancer

Status: UNKNOWN
Phase: EARLY_PHASE1

Patient Perspectives in Squamous Cell Carcinoma Clinical Trials

Status: NOT_YET_RECRUITING
Phase: N/A

A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers

Status: RECRUITING
Phase: PHASE1/PHASE2

Dose Optimized BNCT for Head and Neck Cancer

Status: UNKNOWN
Phase: PHASE1

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

Status: ACTIVE_NOT_RECRUITING
Phase: N/A

Neo-adjuvant Treatment for Squamous Cell Carcinoma Using Direct Tumor Injection With RP1.

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

Serum Exosomal miRNA Predicting the Therapeutic Efficiency in Lung Squamous Carcinoma

Status: UNKNOWN
Phase: N/A

Buccal Cancer Resection Ultrasound Guided

Status: NOT_YET_RECRUITING
Phase: NA

3D Ultrasound, Specimen Examination by Surgeon, and MRI in Surgical Margin Assessment

Status: UNKNOWN
Phase: NA

Surgical Margin Assessment by 3D Ultrasound

Status: UNKNOWN
Phase: NA

Cemiplimab/Peg-Interferon-α in Advanced CSCC

Status: WITHDRAWN
Phase: PHASE1

Survival and Prognostic Factors of Squamous Cell Carcinoma of the Nasal Vestibule

Status: RECRUITING
Phase: N/A

Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Mentored Community Gardening for Individuals With Skin Cancer

Status: COMPLETED
Phase: NA

T1 Squamous Cell Carcinomas of the Lip

Status: UNKNOWN
Phase: N/A

A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2